How Has The Size And Value Of The Fibrin Sealants Market Changed During The 2026–2030 Period?
The fibrin sealants market size has grown strongly in recent years. It will grow from $1.17 billion in 2025 to $1.27 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to limited availability of recombinant and synthetic sealants, reliance on autologous and bovine-derived sealants, increasing surgical procedures, rising awareness about hemostasis, adoption of fibrin sealants in general surgeries.
The fibrin sealants market size is expected to see strong growth in the next few years. It will grow to $1.73 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to advancements in recombinant fibrin production, growth in minimally invasive and robotic surgeries, increasing demand in cardiovascular and orthopedic procedures, rising regulatory approvals and quality certifications, development of bioabsorbable and multifunctional sealants. Major trends in the forecast period include rising adoption of fibrin sealants in minimally invasive surgeries, increasing use of recombinant and synthetic sealants, expansion of orthopedic and cardiovascular surgeries, growing focus on blood conservation and hemostasis, rising preference for bioabsorbable and patch-based sealants.
Claim Your Free Report Sample Today:
What Drivers Are Contributing To The Expansion Trajectory Of The Fibrin Sealants Market?
The increasing number of cosmetic surgeries is expected to propel the growth of the fibrin sealants market going forward. Cosmetic surgeries refer to medical procedures that are primarily focused on enhancing or altering a person's appearance. Cosmetic surgeries are rising due to societal emphasis on appearance, advancements in surgical techniques, and the growing accessibility of minimally invasive procedures. Fibrin sealants help in cosmetic surgeries, promote faster wound healing, reduce bleeding, and minimize scarring, enhancing surgical outcomes and patient recovery. For instance, in September 2023, according to CosmetAssure, a US-based American Society of Plastic Surgeons, liposuction remained the most in-demand plastic surgery procedure in 2023, with 347,782 procedures performed, a 7% increase from 2022, and tummy tucks also saw a 5% rise, with 170,110 procedures performed. Therefore, the increasing number of cosmetic surgeries drives the fibrin sealants market.
Which Primary Segments Are Included In The Detailed Analysis Of The Fibrin Sealants Market?
The fibrin sealants market covered in this report is segmented –
1) By Type: Liquid, Patch, Powder
2) By Technology: Autologous Donation, Viral Inactivation, Recombinant Production, Other Technologies
3) By Application: General Surgery, Cardiovascular Surgery, Wound Management, Orthopedic Surgery, Urological Surgeries, Ophthalmic Surgeries, Transplant Surgery, Other Applications
4) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Liquid: Bovine-Derived Liquid Sealants, Human-Derived Liquid Sealants, Synthetic Liquid Sealants, Recombinant Fibrin Sealants
2) By Patch: Bovine-Derived Fibrin Patches, Human-Derived Fibrin Patches, Synthetic Fibrin Patches, Bioabsorbable Fibrin Patches
3) By Powder: Bovine-Derived Fibrin Powder, Human-Derived Fibrin Powder, Synthetic Fibrin Powder, Recombinant Fibrin Powder
Which Rising Trends Are Anticipated To Influence The Future Trajectory Of The Fibrin Sealants Market?
Major companies operating in the Fibrin Sealants market are focusing on developing innovative solutions, such as fibrin sealant, to enhance hemostasis, reduce surgical complications, improve wound healing outcomes, and optimize patient recovery across various surgical procedures. Fibrin sealants, also known as fibrin glues, are biological adhesive products derived from human or animal blood components that mimic the final stages of the natural blood clotting process. For instance, in October 2024, Grifols S.A., a Spain-based global biopharmaceutical company, received FDA approval for its fibrin sealant solution to treat surgical bleeding in pediatric patients. This product is designed to enhance surgical safety, improve clot formation at the wound site, and reduce the risk of postoperative complications, offering a specialized option for pediatric surgeries where precise hemostasis is critical. The solution can be used across various surgical settings, providing versatility and efficiency compared to conventional approaches.
Which Major Corporations Play A Crucial Role In The Fibrin Sealants Market Landscape?
Major companies operating in the fibrin sealants market are Johnson & Johnson, Takeda Pharmaceutical Company Limited, Asahi Kasei Medical Co. Ltd., Baxter International Inc., CSL Behring, Grifols S.A., Sigma-Aldrich, Nordson Corporation, Integra LifeSciences Corporation, Shanghai RAAS Blood Products Co. Ltd., Mallinckrodt Pharmaceuticals, Biotest AG, LFB Group, Hualan Biological Engineering Inc., Corza Medical, Aesculap Inc., Ethicon Inc., CryoLife Inc., VIVEX Biologics Inc., MediWound Ltd., Cohesion Technologies Inc
Get Your In-Depth Fibrin Sealants Market Report Now:
Which Regions Demonstrate The Highest Growth Momentum In The Fibrin Sealants Market?
North America was the largest region in the fibrin sealants market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fibrin sealants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: Market Research Reports
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Comments
Post a Comment